Professional Summary
Professional Overview
Matt Whitmire is a seasoned finance executive with over 14 years of experience in the biotechnology and healthcare industries. As the Vice President of Finance at Janux Therapeutics, he oversees the company's financial planning, analysis, and strategic decision-making processes, playing a crucial role in supporting the organization's growth and innovation.
Experience Summary
Current Role
As the Vice President of Finance at Janux Therapeutics since August 2024, Matt is responsible for leading the company's financial strategy, budgeting, and forecasting initiatives. He collaborates closely with the executive team to ensure financial alignment with Janux's long-term objectives, while also providing valuable insights to drive informed decision-making. Under his leadership, the finance department has streamlined processes, improved data-driven analysis, and enhanced the company's financial reporting capabilities.
Career Progression
Prior to his current role, Matt held various leadership positions within the biotechnology and healthcare sectors. As the Head of FP&A at Janux Therapeutics, he was instrumental in optimizing the company's financial planning and analysis functions, enabling more efficient resource allocation and strategic planning. Earlier in his career, Matt served as the Clinical Outsourcing Lead and Financial Planning and Analysis Specialist at Mirati Therapeutics, where he played a key role in managing complex financial projects and driving financial strategies to support the company's clinical trial initiatives.
Matt's experience also includes roles at Veyo, where he served as the Senior Director of Data Science and Analytics and the Director of Pricing and Market Analytics, and AArete, where he held various healthcare-focused management and consulting positions. He began his career at EY, where he gained valuable experience in financial auditing and advisory services.
Academic Background
Matt holds a Bachelor of Science degree in Accounting from the University of California, San Diego. He is a Certified Public Accountant (CPA) and has completed additional executive education programs in financial management and strategic decision-making.
Areas of Expertise
- Financial planning, analysis, and strategic decision-making
- Financial reporting and performance management
- Corporate budgeting, forecasting, and resource allocation
- Financial modeling and data-driven analysis
- Cross-functional collaboration and strategic alignment
- Leadership and team management
Professional Impact
Throughout his career, Matt has demonstrated a strong track record of driving financial excellence and supporting the growth of biotechnology and healthcare organizations. At Janux Therapeutics, he has played a pivotal role in optimizing the company's financial operations, enabling more effective resource allocation and positioning the organization for continued success. Matt's expertise in financial planning, analysis, and strategic decision-making has been instrumental in supporting Janux's innovative R&D initiatives and advancing the company's mission to develop transformative therapies.
Conclusion
With his extensive experience, strong analytical skills, and strategic mindset, Matt Whitmire is well-positioned to continue contributing to the success of Janux Therapeutics and making a meaningful impact in the biotechnology industry.
